Similar articles for PMID: 19493260

Year	Number of Results
1997	3
1998	1
1999	3
2000	6
2001	1
2002	4
2003	4
2004	18
2005	10
2006	10
2007	5
2008	6
2009	12
2010	16
2011	15
2012	21
2013	14
2014	12
2015	3
2016	4
2017	2
2018	3
2019	1
2020	4
2022	2
2023	0

1

Outcomes for patients with high-grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy.

Stock RG, Cesaretti JA, Hall SJ, Stone NN. Stock RG, et al. BJU Int. 2009 Dec;104(11):1631-6. doi: 10.1111/j.1464-410X.2009.08661.x. Epub 2009 Jun 2. BJU Int. 2009. PMID: 19493260

2

Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.

Martinez AA, Demanes DJ, Galalae R, Vargas C, Bertermann H, Rodriguez R, Gustafson G, Altieri G, Gonzalez J. Martinez AA, et al. Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1322-31. doi: 10.1016/j.ijrobp.2004.12.053. Int J Radiat Oncol Biol Phys. 2005. PMID: 16029788

3

Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy.

Stone NN, Potters L, Davis BJ, Ciezki JP, Zelefsky MJ, Roach M, Shinohara K, Fearn PA, Kattan MW, Stock RG. Stone NN, et al. Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):341-6. doi: 10.1016/j.ijrobp.2008.04.038. Epub 2008 Jul 1. Int J Radiat Oncol Biol Phys. 2009. PMID: 18597953

4

Intermediate-risk localized prostate cancer in the PSA era: radiotherapeutic alternatives.

Gondi V, Deutsch I, Mansukhani M, O'Toole KM, Shah JN, Schiff PB, Katz AE, Benson MC, Goluboff ET, Ennis RD. Gondi V, et al. Urology. 2007 Mar;69(3):541-6. doi: 10.1016/j.urology.2006.12.015. Urology. 2007. PMID: 17382161

5

High-dose radiation employing external beam radiotherapy and high-dose rate brachytherapy with and without neoadjuvant androgen deprivation for prostate cancer patients with intermediate- and high-risk features.

Vargas C, Martínez A, Galalae R, Demanes J, Harsolia A, Schour L, Nuernberg N, Gonzalez J. Vargas C, et al. Prostate Cancer Prostatic Dis. 2006;9(3):245-53. doi: 10.1038/sj.pcan.4500882. Epub 2006 Jun 20. Prostate Cancer Prostatic Dis. 2006. PMID: 16786040

6

Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.

Kupelian P, Thames H, Levy L, Horwitz E, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A, Kuban D. Kupelian P, et al. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):795-9. doi: 10.1016/j.ijrobp.2005.03.029. Epub 2005 May 31. Int J Radiat Oncol Biol Phys. 2005. PMID: 15925452

7

Unification of a common biochemical failure definition for prostate cancer treated with brachytherapy or external beam radiotherapy with or without androgen deprivation.

Fitch DL, McGrath S, Martinez AA, Vicini FA, Kestin LL. Fitch DL, et al. Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1430-9. doi: 10.1016/j.ijrobp.2006.03.024. Epub 2006 Jun 12. Int J Radiat Oncol Biol Phys. 2006. PMID: 16765527

8

Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.

Miller N, Smolkin ME, Bissonette E, Theodorescu D. Miller N, et al. Cancer. 2005 Jun 15;103(12):2499-506. doi: 10.1002/cncr.21077. Cancer. 2005. PMID: 15852361 Free article.

9

Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment.

Stromberg JS, Martinez AA, Horwitz EM, Gustafson GS, Gonzalez JA, Spencer WF, Brabbins DS, Dmuchowski CF, Hollander JB, Vicini FA. Stromberg JS, et al. Cancer J Sci Am. 1997 Nov-Dec;3(6):346-52. Cancer J Sci Am. 1997. PMID: 9403047 Clinical Trial.

10

Changing the patterns of failure for high-risk prostate cancer patients by optimizing local control.

Stock RG, Ho A, Cesaretti JA, Stone NN. Stock RG, et al. Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):389-94. doi: 10.1016/j.ijrobp.2006.05.072. Int J Radiat Oncol Biol Phys. 2006. PMID: 16965991

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

156 results

Results by year